Here's a review of ten abstracts and presentations on spondyloarthritis encompassing a wide range of topics from etiology to diagnosis to treatment.Read Article
#BestACR20Tweets RT @KDAO2011 : FDA updates 6/16/20 canakinumab for AOSD 5/29/20 ixekizumab for nr-AxSpa 80 mg q4wks 3/9/20 nintedanib for progressive ILD 1/29/20 and 6/16/20 secukinumab nr-axSpa 150 mg q4wks, AS 300 mg SQ q4weeks 1/17/20 belimumab label for black pts removed
#BestACR20Tweets "RT @KDAO2011 : Meta-analysis of studies - 4104 pregnancies axSpa/PsA: higher risk for: preterm labor, small for gestational age, C-section No change in miscarriage/stillbirth, gest.diabetes #ACR20, @rheumnow Abstr#1771 https://t.co/xl1YyRPavX
Watch our video titled Pregnancy in Spondyloarthritis. Dr Richard Conway ( @RichardPAConway) interviews Dr.
@rheumnow #ACR20 abs1535 retrospective study of SI MRI reveals 20% pts w/out spondyloarthritis have BME on an MRI, predominantly in the antero-middle quadrant. Erosions were seen in 31% of healthy patients and in 61% of patients with spondyloarthritis
COX2 inhibitors associated with inhibition of radiographic spinal progression in AxSpA pts compared to non-selective NSAIDs. ⬇️radiographic spinal progression over 2 yrs ⬇️mSASSS progression @RheumNow #ACR20 Abs#2030 https://t.co/p1CeNBm3ma
Gender disparity in Ankylosing Spondylitis symptoms. 1⃣Women ⬆️Achilles tendonitis, plantar fasciitis, joint swelling, BASDAI>40, DMARD use 2⃣HLA-B not associated w/ enthesitis @RheumNow #ACR20 Abs#1872 https://t.co/bxiNUjY1Xh